The chemical substance known as "(+)-202-791," with the CAS number 97217-83-9, is a synthetic compound that has been studied for its potential pharmacological properties. It is characterized by its specific stereochemistry, indicated by the "(+)" sign, which denotes its optical activity and the presence of a particular enantiomer. This compound may exhibit unique biological activities, making it of interest in medicinal chemistry and drug development. Its molecular structure typically includes functional groups that contribute to its reactivity and interactions with biological targets. Research on such compounds often focuses on their efficacy, safety, and mechanism of action, particularly in relation to specific diseases or conditions. Additionally, the compound's solubility, stability, and metabolic pathways are important characteristics that influence its application in therapeutic contexts. As with many synthetic compounds, understanding the structure-activity relationship is crucial for optimizing its use in pharmacology.

(+)-202-791

97217-83-9: (+)-PN 202-791, 3-Pyridinecarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-, 1-methylethyl ester, (4S)-, 2,1,3-Benzoxadiazole, 3-pyridinecarboxylic acid deriv., 3-Pyridinecarboxylic acid, 4-(4-benzofurazanyl)-1,4-dihydro-2,6-dimethyl-5-nitro-, 1-methylethyl ester, (S)-, (S)-(+)-Sandoz 202-791

CAS 97217-83-9: (+)-202-791

3-Pyridinecarboxylic acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-5-nitro-, 1-methylethyl ester, (4S)-

Ref: IN-DA0004A8